MI - Nursing Case Study
Pathophysiology
• Primary mechanism: Coronary artery occlusion due to atherosclerotic plaque rupture leads to reduced blood flow, causing myocardial ischemia and subsequent infarction. The lack of oxygenated blood results in myocardial cell death and tissue necrosis.
• Secondary mechanism: Inflammatory response and platelet aggregation at the site of plaque rupture exacerbate the occlusion. This process can enhance clot formation (thrombosis), further obstructing blood flow and expanding the area of infarction.
• Key complication: Left ventricular dysfunction due to the loss of functional myocardium impairs cardiac output, potentially leading to heart failure. Additionally, electrical instability may result in life-threatening arrhythmias.
Patient Profile
Demographics:
56-year-old male, construction worker
History:
• Key past medical history: Hypertension, hyperlipidemia, and smoking history of 20 pack-years
• Current medications: Lisinopril, atorvastatin, low-dose aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Chest pain radiating to the left arm
• Key symptoms: Shortness of breath, nausea, diaphoresis, and fatigue
• Vital signs: Blood pressure 145/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 90% on room air
Section 1
As the patient is admitted to the cardiac care unit, the healthcare team conducts a thorough initial assessment. The nurse notes that the patient is visibly anxious and diaphoretic, with persistent chest pain rated as 8 out of 10 on the pain scale. Upon auscultation, lung sounds reveal bilateral crackles at the bases, indicating potential pulmonary congestion. A 12-lead ECG is obtained, showing ST-segment elevation in the anterior leads, consistent with an anterior wall myocardial infarction. These findings suggest significant myocardial damage and warrant immediate intervention to restore coronary blood flow.
Laboratory results further confirm the severity of the situation. Troponin levels are markedly elevated, indicating ongoing myocardial injury. The nurse also observes the patient's urine output has decreased to 20 mL/hour over the past two hours, raising concerns about renal perfusion and potential acute kidney injury secondary to decreased cardiac output. The patient's oxygen saturation remains low at 88% despite supplemental oxygen, reinforcing the suspicion of compromised cardiac function and developing heart failure.
Given these assessment findings, the healthcare team initiates treatment with intravenous nitroglycerin to alleviate chest pain and reduce cardiac workload. Continuous cardiac monitoring is essential to detect any arrhythmias, a common complication in the setting of myocardial infarction. The nurse prepares to assist with the administration of a thrombolytic agent, as the patient is a candidate for reperfusion therapy. The evolving clinical picture emphasizes the need for vigilant monitoring and prompt intervention to stabilize the patient's condition and prevent further complications.
Section 2
As the treatment progresses, the patient's response to interventions becomes a critical focus for the healthcare team. Despite the administration of intravenous nitroglycerin, the patient's chest pain remains persistent, now rated as 6 out of 10. Although there is a slight improvement, it indicates that myocardial oxygen demand is still not adequately met. Continuous cardiac monitoring reveals frequent premature ventricular contractions (PVCs), an early sign of potential arrhythmic complications. The nurse recognizes that these arrhythmias can exacerbate myocardial ischemia and further compromise cardiac output, necessitating close observation and potential adjustment of pharmacologic therapy.
In conjunction with the cardiac issues, the patient's respiratory status shows signs of further deterioration. Oxygen saturation has decreased to 85%, and the patient reports increased dyspnea. Auscultation of the lungs now reveals more pronounced crackles extending beyond the bases, pointing to worsening pulmonary edema. This development suggests that the heart's pumping efficiency is declining, leading to fluid accumulation in the lungs. The nurse collaborates with the healthcare team to initiate diuretic therapy with intravenous furosemide to address fluid overload and improve oxygenation.
Laboratory results reveal that the patient's blood urea nitrogen (BUN) and creatinine levels are rising, confirming the suspicion of acute kidney injury. This renal impairment is likely secondary to decreased perfusion and possibly exacerbated by the current interventions. The healthcare team must carefully balance the need to reduce cardiac workload while ensuring that renal function does not deteriorate further. The evolving clinical picture highlights the complexity of managing a myocardial infarction with concurrent heart failure and renal compromise, requiring ongoing assessment and timely intervention to stabilize the patient's condition and prevent further complications.
Section 3
As the healthcare team continues to monitor the patient's condition, new diagnostic results provide further insight into the evolving clinical picture. A follow-up electrocardiogram (ECG) shows ST-segment elevation in additional leads, suggesting that the myocardial infarction is extending. This finding is concerning as it indicates ongoing ischemia despite current therapeutic measures. Concurrently, troponin levels are significantly elevated, corroborating the suspicion of myocardial injury and highlighting the need for more aggressive intervention to halt the progression of cardiac damage.
In light of these developments, the patient's hemodynamic status also reflects changes. Blood pressure readings have dropped to 90/60 mmHg, indicating a potential decrease in cardiac output and perfusion pressure. Heart rate remains elevated at 110 beats per minute, likely a compensatory response to maintain blood flow. The nurse notes that despite the administration of diuretics, the patient's urine output is minimal, further confirming renal hypoperfusion and emphasizing the delicate balance required in managing fluid status without compromising renal function.
These diagnostic findings prompt the healthcare team to reconsider the current treatment plan. The persistence of ischemic changes on the ECG and hemodynamic instability necessitate a reassessment of pharmacologic strategies, possibly including the escalation of vasopressor support to stabilize blood pressure and enhance cardiac perfusion. Additionally, the team evaluates the need for advanced cardiac interventions, such as percutaneous coronary intervention (PCI), to restore coronary blood flow and prevent further myocardial damage. Recognizing the interconnectedness of cardiac, respiratory, and renal systems, the team must remain vigilant in their clinical reasoning to ensure comprehensive and cohesive care.
Section 4
In response to the concerning signs of ongoing myocardial ischemia and hemodynamic instability, the healthcare team initiates an escalation in therapeutic interventions. Vasopressor support is introduced with a low-dose norepinephrine infusion to stabilize the patient's blood pressure and improve coronary perfusion. Shortly after initiation, the patient's blood pressure shows a modest improvement, rising to 100/65 mmHg, yet the heart rate remains elevated at 108 beats per minute. The nurse closely monitors for any adverse effects, ensuring that perfusion to vital organs is maintained. Despite these efforts, the patient begins to exhibit mild respiratory distress with an increased respiratory rate of 24 breaths per minute and an oxygen saturation that has dropped to 92% on room air. Supplemental oxygen is provided to maintain adequate oxygenation.
Concurrent with these interventions, new laboratory results reveal a worsening metabolic acidosis, with an arterial blood gas showing a pH of 7.32, HCO3- of 18 mEq/L, and PaCO2 of 35 mmHg. This metabolic derangement suggests an accumulation of lactic acid due to poor tissue perfusion, further challenging the clinical team to address the underlying cause. Renal function tests show an increase in serum creatinine to 2.2 mg/dL, indicating a potential progression towards acute kidney injury, likely secondary to ongoing renal hypoperfusion. The minimal urine output persists despite adjustments in fluid management, necessitating a delicate balance between fluid resuscitation and the risk of exacerbating cardiac workload.
These developments prompt the healthcare team to consider additional interventions. Given the patient's worsening respiratory status and metabolic imbalance, the potential need for mechanical ventilation is evaluated to support respiratory effort and correct acid-base disturbances. The team also reassesses the appropriateness of moving forward with emergent percutaneous coronary intervention (PCI) to promptly address coronary occlusion and mitigate further cardiac damage. This challenging clinical scenario underscores the necessity for dynamic clinical reasoning and interprofessional collaboration to navigate the complex interplay of systems and optimize patient outcomes.
Section 5
Following the initiation of supplemental oxygen and evaluation for possible mechanical ventilation, the patient's respiratory status and metabolic acidosis remain a focal point. Despite the supplemental oxygen, the patient's oxygen saturation remains at 92%, and the increased work of breathing persists. Recognizing the potential for respiratory fatigue, the healthcare team decides to intubate the patient to ensure adequate ventilation and oxygenation. Post-intubation, the arterial blood gas is reassessed, revealing a slight improvement in oxygenation with a PaO2 of 80 mmHg, but the metabolic acidosis persists with a pH of 7.30 and HCO3- of 17 mEq/L. The PaCO2 is now 38 mmHg, indicating that while ventilation is adequate, the underlying metabolic issue is yet to be resolved.
Simultaneously, new diagnostic results from cardiac enzymes show a significant rise in troponin levels, confirming ongoing myocardial injury. The troponin I level has increased to 12 ng/mL, emphasizing the urgency of addressing potential coronary occlusion. An echocardiogram is performed, revealing reduced left ventricular ejection fraction at 35%, suggesting compromised cardiac function and reinforcing the need for emergent percutaneous coronary intervention (PCI). The team prepares to transport the patient to the catheterization lab, aiming to restore coronary blood flow and prevent further myocardial damage.
As the patient is stabilized for transport, a new complication arises. The nurse notes a decrease in urine output to 15 mL/hour, and the patient's serum creatinine has further increased to 2.5 mg/dL, indicating worsening renal function. The clinical team discusses the balance between adequate perfusion and the risk of fluid overload, considering the patient's compromised cardiac status. This situation necessitates a careful titration of vasopressors and fluids, highlighting the complexity of managing the interrelated systems in acute myocardial infarction with multi-organ involvement. The focus remains on rapidly addressing the coronary obstruction while maintaining systemic stability as the patient is moved to the interventional suite.